FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Agency | Date | Time | Location |
---|---|---|---|
FDA | March 31, 2006 | 8:00 a.m. - 4:00 p.m. | Food and Drug
Administration |
Agenda:
The Science Board will conclude their discussion on drug safety from the meeting
of November 4, 2006, and will hear about and discuss a request by the agency
for a review of the agency's science programs. The Science Board will then hear
about and discuss the agency's response to the recommendations contained in
the Science Board's peer review of the Office of Regulatory Affairs Pesticide
Program, plans for a Science Board peer review of the Center for Veterinary
Medicine's intramural portion of the National Antimicrobial Resistance Monitoring
System, and the science priorities of the agency's Office of Women's Health
.
Background material and meeting information will become available no later than one business day before the meeting (Simply scroll down to the appropriate committee link).
Procedure:
Interested persons may present data, information, or views, orally or in writing,
on issues pending before the committee. Written submissions may be made to the
contact person by March 24, 2006. Oral presentations from the public will be
scheduled between approximately 1 p.m. and 2 p.m. Time allotted for each presentation
may be limited. Those desiring to make formal oral presentations should notify
the contact person before March 24, 2006, and submit a brief statement of the
general nature of the evidence or arguments they wish to present, the names
and addresses of proposed participants, and an indication of the approximate
time requested to make their presentation. Persons attending FDA's advisory
committee meetings are advised that the agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the public at its advisory committee meetings
and will make every effort to accommodate persons with physical disabilities
or special needs. If you require special accommodations due to a disability,
please contact Jan N. Johannessen at least 7 days in advance of the meeting.
Contact Person:
Jan N. Johannessen, Office of Science and Health Coordination,
Office of the Commissioner (HF-33), Food and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301-827-6687, e-mail: Jan.Johannessen@fda.hhs.gov
Advisory Committee Telephone Information Line:
Please call the Information Line for up-to-date information on this
meeting, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512603.